A study conducted by Israeli researchers in Haifa showed the short-term effectiveness and safety of micro doses of Medical Cannabis administered via a metered-dose inhaler (the Syqe Inhaler) in ...
Israeli med-tech startup Syqe Medical developed a medical marijuana inhaler to address dosing issues. The SyqeAir inhaler is said to provide fast relief without smoking, reduce side effects and enable ...
NEW ORLEANS, La - A company under the license of Southern University today announced an exclusive partnership to produce an inhalable medical cannabis formulation to benefit Louisiana Veterans ...
TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (LABS:CA) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specializing in precision ...
JERUSALEM (Reuters) - Israel's Teva Pharmaceuticals has partnered with Tel Aviv-based Syqe Medical to market in Israel medical cannabis for pain management that is administered with an inhaler. The ...
According to Health Canada, the Canadian medical cannabis market currently contains 320,000 registered patients, and an estimated total of 8 million Canadians experience chronic pain. An Israeli ...
VANCOUVER, July 10, 2019 /CNW/ - Vapen MJ Ventures (CSE: VAPN) ("Vapen MJ") a fully integrated agricultural technology, services and property management company in the regulated cannabis industry, ...
SyqeAir is a revolutionary medical device designed to administer low, metered, and consistent doses of medicinal cannabis by inhalation, aerosolised from dried milled flowers. It has undergone ...
A recent study published in Canadian Journal of Health Technologies examined the effectiveness of using metered-dose inhalers (MDIs) for medical cannabis and the evidence based guidelines for MDI use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback